Aktis Oncology Enters Into Strategic Collaboration With Lilly to ...

May 21, 2024 · Aktis Oncology, a biotechnology company discovering and developing novel targeted radiopharmaceuticals to treat a broad range of solid tumors, announced a multi-target …

CouponFollow Extension

$1
OFF

Eli Lilly And Aktis Enter $1bn Partnership To Develop Anticancer ...

4 weeks from now

May 23, 2024 · Eli Lilly has entered into a strategic multi-target discovery collaboration agreement with Aktis Oncology in a deal worth more than $1bn to develop novel anticancer …

pmlive.com

$60
OFF

Lilly Collaborates With Aktis To Strengthen Radiopharma Portfolio

4 weeks from now

May 21, 2024 · Aktis will receive $60m in an upfront payment from Lilly, with the biotech eligible for up to $1.1bn in milestone payments and royalties. ... Eli Lilly is once again expanding its …

pharmaceutical-technology.com

$60
OFF

Aktis Oncology Forms Major Drug-discovery Collaboration With Eli …

4 weeks from now

May 23, 2024 · Under the terms of the agreement, Aktis will receive a $60 million upfront cash payment in addition to an equity investment in Aktis by Lilly. In addition, Aktis will be eligible to …

ncbiotech.org

$1
OFF

Eli Lilly And Aktis Enter $1bn Partnership To Develop Anticancer ...

4 weeks from now

May 23, 2024 · Sign up for the latest from Aktis Oncology. Email address: Leave this field empty if you're human: Contact Us

aktisoncology.com

$60
OFF

Lilly Pays Aktis $60M To Further Dial Into Radiopharma Signal

4 weeks from now

May 21, 2024 · Eli Lilly is continuing to ride the radiopharma wave, paying Aktis Oncology $60 million upfront to work on therapeutic and diagnostic products against multiple targets. Lilly …

fiercebiotech.com

$140
OFF

Lilly Signs $140M Radiopharma Partnership With Radionectics

4 weeks from now

Jul 1, 2024 · Eli Lilly pays Aktis $60M upfront to further dial into radiopharma signal The biotech hauled in a $52.5 million series A at the start of this year, bringing the total the company had …

fiercebiotech.com

FAQs about Aktis Oncology Enters Into Strategic Collaboration With Lilly to ... Coupon?

What is aktis oncology doing with Eli Lilly?

Aktis Oncology, a biotechnology company discovering and developing novel targeted radiopharmaceuticals to treat a broad range of solid tumors, today announced a multi-target discovery collaboration agreement with Eli Lilly and Company to generate anticancer radiopharmaceuticals using Aktis Oncology's novel miniprotein technology platform. ...

What is Aktis Oncology?

Aktis Oncology is a biotechnology company pioneering the discovery and development of novel targeted alpha radiopharmaceuticals to treat a broad range of solid tumor cancers. Founded and incubated by MPM Capital, the company has developed proprietary platforms to generate tumor targeting agents with ideal properties for alpha radiotherapy. ...

Will Aktis partner with Lilly?

Aktis Oncology has entered into a strategic collaboration with Lilly to discover and develop targeted radiopharmaceuticals. Under the terms of the agreement, Aktis will partner with Lilly and receive a $60 million upfront cash payment, along with an equity investment in Aktis by Lilly. ...

Will Lilly acquire aktis pharmaceuticals?

Under the terms of the agreement, Lilly will gain worldwide rights to develop targets for radiopharmaceuticals discovered by Aktis. However, the deal does not include Aktis’ current pipeline, which consists of seven programmes. ...

How much will Lilly invest in Aktis?

Under the terms of the agreement, Aktis will receive an equity investment in Aktis by Lilly in addition to a $60 million upfront cash payment for the collaboration. ...

Why did the Big Pharma pay aktis oncology $60 million?

Then in May of this year, the Big Pharma paid Aktis Oncology $60 million upfront to work on therapeutic and diagnostic products against multiple targets. Aktis has been combining its radioactive isotopes with miniproteins, prioritizing selectivity and tumor penetration. ...